HCA Healthcare (NYSE:HCA) Price Target Raised to $395.00

HCA Healthcare (NYSE:HCA) had its price objective increased by stock analysts at Wells Fargo & Company from $365.00 to $395.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price would suggest a potential downside of 3.67% from the company’s previous close.

Several other research analysts also recently weighed in on the company. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Barclays boosted their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. KeyCorp started coverage on HCA Healthcare in a report on Friday, October 11th. They set an “overweight” rating and a $475.00 target price on the stock. Finally, Oppenheimer lifted their price objective on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $367.15.

HCA Healthcare Stock Performance

NYSE HCA opened at $410.03 on Tuesday. HCA Healthcare has a fifty-two week low of $215.96 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The firm has a market capitalization of $107.39 billion, a P/E ratio of 20.44, a PEG ratio of 1.44 and a beta of 1.67. The stock has a 50-day simple moving average of $394.72 and a two-hundred day simple moving average of $352.30.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the firm earned $4.29 EPS. On average, equities analysts forecast that HCA Healthcare will post 22.51 earnings per share for the current year.

Insider Activity

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,345 shares of company stock valued at $5,747,945. 1.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Terra Nova Asset Management LLC lifted its holdings in HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after buying an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV lifted its stake in HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after purchasing an additional 29 shares during the last quarter. Waldron Private Wealth LLC increased its stake in HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares during the last quarter. Brookstone Capital Management boosted its holdings in shares of HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock valued at $1,652,000 after buying an additional 30 shares in the last quarter. Finally, UMB Bank n.a. raised its stake in HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after acquiring an additional 30 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.